Despite the complexity of cancer immunoediting [3], growing evidences suggest that the co-inhibitory receptors, such as cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and programmed death 1 (PD-1), play a crucial role in cancer immunoediting, especially in the equilibrium and escape stages [4]. Here, CTLA4 is linked to cancer.